Euroapi SAS banner
E

Euroapi SAS
PAR:EAPI

Watchlist Manager
Euroapi SAS
PAR:EAPI
Watchlist
Price: 1.274 EUR -1.55% Market Closed
Market Cap: €121.8m

Euroapi SAS
Common Shares Outstanding

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Euroapi SAS
Common Shares Outstanding Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
E
Euroapi SAS
PAR:EAPI
Common Shares Outstanding
€95.2m
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Sanofi SA
PAR:SAN
Common Shares Outstanding
€1.2B
CAGR 3-Years
-1%
CAGR 5-Years
-1%
CAGR 10-Years
-1%
Ipsen SA
PAR:IPN
Common Shares Outstanding
€82.4m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Vetoquinol SA
PAR:VETO
Common Shares Outstanding
€11.8m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Virbac SA
PAR:VIRP
Common Shares Outstanding
€8.4m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Medincell SA
PAR:MEDCL
Common Shares Outstanding
€33.1m
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
N/A
No Stocks Found

Euroapi SAS
Glance View

Market Cap
121.8m EUR
Industry
Pharmaceuticals

EUROAPI SA operates as a manufacturer and supplier of active pharmaceutical ingredient solutions for healthcare companies. The company is headquartered in Paris, Ile-De-France and currently employs 3,342 full-time employees. The company went IPO on 2022-05-06. The firm is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc. ), analgesics, etc. The firm also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. The company has production sites located in France, the United Kingdom, Germany, Italy and Hungary.

EAPI Intrinsic Value
5.419 EUR
Undervaluation 76%
Intrinsic Value
Price €1.274
E

See Also

What is Euroapi SAS's Common Shares Outstanding?
Common Shares Outstanding
95.2m EUR

Based on the financial report for Dec 31, 2025, Euroapi SAS's Common Shares Outstanding amounts to 95.2m EUR.

What is Euroapi SAS's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
1%

Over the last year, the Common Shares Outstanding growth was 0%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett